RecruitingNot ApplicableNCT06636539

Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device


Sponsor

Hologic, Inc.

Enrollment

75 participants

Start Date

Oct 14, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective, multi-center image case collection study to acquire de-identified contrast-enhanced breast images on a mammography device to support continuing software technology development. Eligible subjects include women at least 35 years old with a suspicious finding or breast abnormality on a screening or diagnostic mammogram who are indicated for a diagnostic exam or a biopsy procedure.


Eligibility

Sex: FEMALEMin Age: 35 Years

Inclusion Criteria4

  • Subject is female of any race and ethnicity.
  • Subject is at least 35 years old
  • Subject has a suspicious finding or breast abnormality on a screening or diagnostic mammogram and is indicated for a diagnostic exam or a biopsy procedure.
  • Subject is able to read, understand, and sign the study-specific informed consent form (ICF) after the nature of the study has been fully explained to them.

Exclusion Criteria10

  • Subject is unable or unwilling to undergo informed consent or subject who requires a Legally Authorized Representative (LAR) for Informed Consent.
  • Subject has breast implants, cardiac pacemakers, nipple piercings, or IV ports in the mammography field of view in the breast of interest.
  • Subject has had an interventional procedure in the same breast as the suspicious finding within the last six (6) months
  • Subject is pregnant or presumed to be pregnant.
  • Subject is breastfeeding.
  • Subject is actively being treated for cancer of any type with chemotherapy
  • Subject is suspected to be at risk of complications from the iodinated contrast agent. These include contra-indications of standard iodinated contrast agents, such as the subject having renal insufficiency) and the subject being on dialysis.
  • Subject has had a prior reaction to iodinated contrast; thus, a known allergy to iodinated contrast.
  • Subject has had a prior reaction to gadolinium contrast agents; thus, a known allergy to gadolinium contrast.
  • Subject who, based on the physician's judgment, may be at increased risk for complications associated with renal function, anticoagulant therapy, or bleeding disorders.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECEM Software in New Mammography Device

All subjects enrolled in the study will undergo a CEM exam.


Locations(2)

Solis Mammography Memorial Village

Houston, Texas, United States

Washington Radiology Sterling

Sterling, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06636539